Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Levy

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
American Journal of Hematology|November 28, 2014
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)Anne Quinquenel, Christophe Willekens, Jehan Dupuis, et al.
Cancer Immunology, Immunotherapy : CII|June 22, 2010
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumorsJaafar Bennouna, Vincent Levy, Hélène Sicard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemiaYuri Vasconcelos, Frédéric Davi, Vincent Levy, et al.
Melanoma Research|October 28, 2009
Interest in an original methodology to define the optimal dosage of interferon-alpha-2a in metastatic melanoma patientsSarah Zohar, Jacques Medioni, Céleste Lebbé, et al.
American Journal of Hematology|May 3, 2016
Efficacy and long-term toxicity of the rituximab-fludarabine-cyclophosphamide combination therapy in Waldenstrom's macroglobulinemiaLaetitia Souchet, Vincent Levy, Maya Ouzegdouh, et al.
Asian Journal of Andrology|June 25, 2013
Obesity leads to higher risk of sperm DNA damage in infertile patientsCharlotte Dupont, Céline Faure, Nathalie Sermondade, et al.
American Journal of Hematology|September 30, 2014
Old DAT and new data: positive direct antiglobulin test identifies a subgroup with poor outcome among chronic lymphocytic leukemia stage A patientsAnne Quinquenel, Chadi Al Nawakil, Fanny Baran-Marszak, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2012
Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II studyEric Van Den Neste, Bruno Cazin, Ann Janssens, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 30, 2012
Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patientsThomas Aparicio, Olivier Schischmanoff, Cecile Poupardin, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 12, 2002
Identification of prognostic factors in post-transplant lymphoproliferative disordersSylvain Choquet, Bruneel Marie-France Mamzer, Olivier Hermine, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
American Journal of Hematology|November 28, 2014
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)Anne Quinquenel, Christophe Willekens, Jehan Dupuis, et al.
Cancer Immunology, Immunotherapy : CII|June 22, 2010
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumorsJaafar Bennouna, Vincent Levy, Hélène Sicard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemiaYuri Vasconcelos, Frédéric Davi, Vincent Levy, et al.
Melanoma Research|October 28, 2009
Interest in an original methodology to define the optimal dosage of interferon-alpha-2a in metastatic melanoma patientsSarah Zohar, Jacques Medioni, Céleste Lebbé, et al.
American Journal of Hematology|May 3, 2016
Efficacy and long-term toxicity of the rituximab-fludarabine-cyclophosphamide combination therapy in Waldenstrom's macroglobulinemiaLaetitia Souchet, Vincent Levy, Maya Ouzegdouh, et al.
Asian Journal of Andrology|June 25, 2013
Obesity leads to higher risk of sperm DNA damage in infertile patientsCharlotte Dupont, Céline Faure, Nathalie Sermondade, et al.
American Journal of Hematology|September 30, 2014
Old DAT and new data: positive direct antiglobulin test identifies a subgroup with poor outcome among chronic lymphocytic leukemia stage A patientsAnne Quinquenel, Chadi Al Nawakil, Fanny Baran-Marszak, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2012
Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II studyEric Van Den Neste, Bruno Cazin, Ann Janssens, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 30, 2012
Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patientsThomas Aparicio, Olivier Schischmanoff, Cecile Poupardin, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 12, 2002
Identification of prognostic factors in post-transplant lymphoproliferative disordersSylvain Choquet, Bruneel Marie-France Mamzer, Olivier Hermine, et al.
Pageof 6